Oracle and Eli Lilly Flag as Deeply Undervalued in GF Value Scan as Forward Industries Signals Speculative Excess
Oracle (ORCL) and Eli Lilly (LLY) show 22.6% and 25.1% undervaluation on GF Value respectively, with Eli Lilly’s oral GLP-1 now reaching one-third of new patients
Key points
- Oracle (ORCL) and Eli Lilly (LLY) show 22.6% and 25.1% undervaluation on GF Value respectively, with Eli Lilly’s oral GLP-1
- Forward Industries (FWDI) flagged at 5,735% overvaluation after massively expanding its Solana treasury holdings in a MicroStrategy-style crypto pivot
- American Airlines (AAL) faces FAA-mandated flight suspensions at Philadelphia and Newark, adding operational disruption to already challenging macro headwinds
What’s your take on this? Join the discussion below.
Read the full analysis on market.news
🇺🇸 United States Stocks Value-Investing gf-value value-investing oracle eli-lilly